• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue7

Evolution Of Multidrug Resistance Superbugs, A Healthcare Nightmare – Short Review

    Neha Singh Ghosh M

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 4378-4382

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Antibiotics resistance are increasing. Public health officials are alarmed by the increasing frequency of antimicrobial- resistant microorganisms that have been remerged in the hospitals. There is sufficient tales to remind us that antibiotics might lose all the potency against invading bacteria. The development of resistance from the evolution of the elegant resistance mechanisms that create superbugs, which is spread by exchange resistance traits with other microorganisms. The Centre for Disease Control and Prevention estimates that more than 2 million people annually are sicken from the drug-resistance bacteria. The antibiotic resistance is particularly destructive in hospitals, where such infections strike the patients with chronic disease and weak immune systems. High risk groups includes individuals who have undergone recent surgery, the cancer patients, diabetics etc.Selection intensity is the major contributor to the resistance which can be determined by the volume of drugs consumption by human and agricultural industry. Cost to fitness of the microorganism is associated by acquired or De novo resistance. Therefore it is assume that reduction of the prevalence of resistance can be carried out by reducing the volume of drug use
Keywords:
    Antimicrobial resistance Multidrug- resistance Conjugation inhibitors
  • PDF (338 K)
  • XML
(2020). Evolution Of Multidrug Resistance Superbugs, A Healthcare Nightmare – Short Review. European Journal of Molecular & Clinical Medicine, 7(7), 4378-4382.
Neha Singh; Ghosh M. "Evolution Of Multidrug Resistance Superbugs, A Healthcare Nightmare – Short Review". European Journal of Molecular & Clinical Medicine, 7, 7, 2020, 4378-4382.
(2020). 'Evolution Of Multidrug Resistance Superbugs, A Healthcare Nightmare – Short Review', European Journal of Molecular & Clinical Medicine, 7(7), pp. 4378-4382.
Evolution Of Multidrug Resistance Superbugs, A Healthcare Nightmare – Short Review. European Journal of Molecular & Clinical Medicine, 2020; 7(7): 4378-4382.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 52
  • PDF Download: 82
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus